These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33141418)

  • 21. SMARCB1 (INI1)-Deficient Sinonasal Carcinoma with Yolk Sac differentiation Showing Co-loss of SMARCA4 Immunostaining - A Case Report and Literature Review.
    Ng JKM; Chan JYK; Li JJX; Tang K; Yeung DCM; Chan ABW
    Head Neck Pathol; 2022 Sep; 16(3):934-941. PubMed ID: 35257325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of
    Chitguppi C; Rabinowitz MR; Johnson J; Bar-Ad V; Fastenberg JH; Molligan J; Berman E; Nyquist GG; Rosen MR; Evans JE; Mardekian SK
    J Neurol Surg B Skull Base; 2020 Dec; 81(6):610-619. PubMed ID: 33381364
    [No Abstract]   [Full Text] [Related]  

  • 23. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology.
    Ramalingam P; Croce S; McCluggage WG
    Histopathology; 2017 Feb; 70(3):359-366. PubMed ID: 27656868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SWI/SNF-deficient Sinonasal Carcinomas.
    Agaimy A
    Adv Anat Pathol; 2023 Mar; 30(2):95-103. PubMed ID: 36580412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA methylation-based classification of sinonasal undifferentiated carcinoma.
    Dogan S; Vasudevaraja V; Xu B; Serrano J; Ptashkin RN; Jung HJ; Chiang S; Jungbluth AA; Cohen MA; Ganly I; Berger MF; Momeni Boroujeni A; Ghossein RA; Ladanyi M; Chute DJ; Snuderl M
    Mod Pathol; 2019 Oct; 32(10):1447-1459. PubMed ID: 31186531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metastatic SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma Diagnosed by Endobronchial Ultrasound-Guided Fine-Needle Aspiration (EBUS-FNA): A Potential Diagnostic Pitfall and Review of the Literature.
    McHugh KE; Policarpio-Nicolas MLC
    Acta Cytol; 2019; 63(5):431-437. PubMed ID: 31132763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunophenotypic features of dedifferentiated endometrial carcinoma - insights from BRG1/INI1-deficient tumours.
    Hoang LN; Lee YS; Karnezis AN; Tessier-Cloutier B; Almandani N; Coatham M; Gilks CB; Soslow RA; Stewart CJ; Köbel M; Lee CH
    Histopathology; 2016 Oct; 69(4):560-9. PubMed ID: 27101785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytopathologic features of SMARCB1 (INI-1)-deficient sinonasal carcinoma.
    Allard FD; Bell D; Stelow EB
    Cancer Cytopathol; 2018 Aug; 126(8):567-574. PubMed ID: 29797680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SMARCA4-deficient Sinonasal Carcinoma: A Series of 10 Cases Expanding the Genetic Spectrum of SWI/SNF-driven Sinonasal Malignancies.
    Agaimy A; Jain D; Uddin N; Rooper LM; Bishop JA
    Am J Surg Pathol; 2020 May; 44(5):703-710. PubMed ID: 31934917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SMARCB1-Deficient Sinonasal Carcinoma: Case Report and Review of the Literature.
    AlMadan NM; AlEssa EA; AlGhamdi DA
    Am J Case Rep; 2023 May; 24():e939244. PubMed ID: 37198880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SMARCB1 deficient sinonasal carcinoma: An emerging entity with a diagnostic challenge.
    Anila KR; Ginju V; Vishnu VL; Kumar R; Jayasree K
    Indian J Pathol Microbiol; 2023; 66(1):159-161. PubMed ID: 36656230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRG1, INI1, and ARID1B Deficiency in Endometrial Carcinoma: A Clinicopathologic and Immunohistochemical Analysis of a Large Series From a Single Institution.
    Kihara A; Amano Y; Matsubara D; Fukushima N; Fujiwara H; Niki T
    Am J Surg Pathol; 2020 Dec; 44(12):1712-1724. PubMed ID: 32910019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract.
    Bishop JA; Antonescu CR; Westra WH
    Am J Surg Pathol; 2014 Sep; 38(9):1282-9. PubMed ID: 25007146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic study of deciduoid mesothelioma using SMARCB1/INI1 immunohistochemistry and fluorescence in situ hybridization.
    Kawai T; Ogata S; Nakashima H; Urabe S; Murakami I; Hiroshima K
    Hum Pathol; 2019 Nov; 93():23-29. PubMed ID: 31445842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SMARCB1-deficient carcinomas of the head and neck region: a cytopathologic characterization.
    Kezlarian BE; Lin O; Dogan S
    J Am Soc Cytopathol; 2020; 9(6):494-501. PubMed ID: 32839151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SMARCB1 (INI-1) - Deficient sinonasal carcinoma: Report of two cases.
    Vasudevan G; Srinivas SP; Nayal B; Jayaprakash P; Ramaswamy B
    Indian J Pathol Microbiol; 2023; 66(2):352-355. PubMed ID: 37077082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
    Pawel BR
    Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncogenic roles of SMARCB1/INI1 and its deficient tumors.
    Kohashi K; Oda Y
    Cancer Sci; 2017 Apr; 108(4):547-552. PubMed ID: 28109176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SMARCB1/INI1-deficient tumors of adulthood.
    Parker NA; Al-Obaidi A; Deutsch JM
    F1000Res; 2020; 9():662. PubMed ID: 33796273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of p16 in sinonasal undifferentiated carcinoma (SNUC) without associated human papillomavirus (HPV).
    Wadsworth B; Bumpous JM; Martin AW; Nowacki MR; Jenson AB; Farghaly H
    Head Neck Pathol; 2011 Dec; 5(4):349-54. PubMed ID: 21805120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.